Introduction | EcoVadis EcoVadis is the largest and most trusted platform for assessing corporate social responsibility and sustainable development around the world, which aims to evaluate th...

Aurisco Pharmaceutical today announced that its manufacturing site in Badu, Tiantai has successfully passed a USFDA cGMP inspection, which lasted for 5 days , from March 17 to March 21,2025. Th...

On May 12, 2025, Luiz Inácio Lula da Silva, President of the Federative Republic of Brazil, met with Peng Zhien, Chairman of Aurisco in Beijing. Aurisco actively aligns with national initiatives,se...

East China Normal University and Aurisco Pharmaceutical Co., Ltd. jointly inaugurated AI-Driven Oligonucleotide Drugs Discovery Laboratory. The signing and inauguration ceremony of the AI-Driven Ol...

Introduction | EcoVadis EcoVadis is the largestand most trusted platform for assessing corporate social responsibility andsustainable development around the world, which aims to evaluate thep...

Aurisco's first oligonucleotide commercial manufacturing line was successfully delivered by Cytiva, accelerating the commercialization process of oligonucleotide drugs.The project was efficien...

On January 19, 2024, Chairman Peng Zhien and Director Li Jinliang of Aurisco Pharmaceutical Co., Ltd. were invited to participate in the "Future Pharmaceutical Industry-University-Research Developm...

Aurisco sets Goals and Plans for Carbon Neutrality by 2027 and Zero Emissions by 2030 Aurisco Pharmaceutical’s mission is to create a better world providing its clients with the highest qual...